Elefante Mark B bought a new stake in Proto Labs, Inc. (NYSE:PRLB – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 58,434 shares of the industrial products company’s stock, valued at approximately $5,302,000. Proto Labs makes up approximately 2.3% of Elefante Mark B’s portfolio, making the stock its 20th biggest holding. Elefante Mark B owned 0.24% of Proto Labs at the end of the most recent quarter.
A number of other institutional investors also recently added to or reduced their stakes in the company. First Nebraska Trust Co acquired a new position in Proto Labs during the 2nd quarter worth approximately $545,000. Kirtland Hills Capital Management LLC acquired a new stake in shares of Proto Labs in the 2nd quarter valued at $408,000. Compass Financial Management LLC purchased a new stake in shares of Proto Labs during the 2nd quarter worth $156,000. Alta Advisers Ltd purchased a new stake in shares of Proto Labs during the 2nd quarter worth $619,000. Finally, XXEC Inc. grew its stake in shares of Proto Labs by 2,060.4% during the second quarter. XXEC Inc. now owns 1,261,547 shares of the industrial products company’s stock worth $111,461,682,000 after purchasing an additional 1,203,154 shares in the last quarter. Hedge funds and other institutional investors own 84.54% of the company’s stock.
Insider Activity at Proto Labs
In other news, Director Sven Wehrwein sold 2,000 shares of Proto Labs stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total transaction of $154,560.00. Following the sale, the director owned 32,505 shares in the company, valued at approximately $2,511,986.40. The trade was a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on PRLB
Proto Labs Trading Down 0.2%
Shares of Proto Labs stock opened at $79.48 on Monday. The company has a fifty day simple moving average of $80.56 and a 200-day simple moving average of $70.31. The stock has a market cap of $1.90 billion, a price-to-earnings ratio of 63.58 and a beta of 1.40. Proto Labs, Inc. has a 12-month low of $45.10 and a 12-month high of $93.00.
Proto Labs (NYSE:PRLB – Get Free Report) last announced its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.53 by $0.07. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The firm had revenue of $149.34 million for the quarter, compared to analyst estimates of $144.53 million. During the same period last year, the business earned $0.41 EPS. Proto Labs’s revenue for the quarter was up 10.5% compared to the same quarter last year. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, analysts forecast that Proto Labs, Inc. will post 1.46 earnings per share for the current fiscal year.
About Proto Labs
Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.
Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.
Recommended Stories
- Five stocks we like better than Proto Labs
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
